Scholarlink

Introduction <p>To evaluate the immediate effects of two artificial tear formulations—mineral oil + hydroxypropyl guar (HP-Guar) and hyaluronic acid (HA) + HP-Guar—on ocular aberrations in healthy participants.</p> Methods <p>A randomized, participant-masked clinical trial was conducted on 98 right eyes of 98 participants (mean age: 27.96 ± 10.00&#xa0;years). Participants received a single instillation of either a lipid-based (mineral oil + HP-Guar) or non-lipid (HA + HP-Guar) artificial tear solution. Ocular aberrations were measured before and 10&#xa0;min post-instillation using a wavefront aberrometer (i.Profilerplus<sup>®</sup>, Carl Zeiss Meditec, Jena, Germany) at pupil diameters of 3&#xa0;mm and 5&#xa0;mm. Root mean square (RMS) values for total, low-order, and high-order aberrations were analyzed.</p> Results <p>The mineral oil + HP-Guar formulation significantly reduced total RMS (<i>p</i> &lt; 0.05) and low-order RMS (<i>p</i> &lt; 0.05) at both 3-mm and 5-mm pupil diameters. Notable reductions were observed in defocus (<i>Z</i><sub>2</sub><sup>0</sup>), vertical astigmatism (<i>Z</i><sub>2</sub><sup>2</sup>), and trefoil (<i>Z</i><sub>3</sub><sup>−3</sup>). Both formulations significantly increased high-order RMS (<i>p</i> &lt; 0.05).</p> Conclusions <p>Lipid-based artificial tears provide superior optical quality by reducing total and low-order ocular aberrations, making them preferable for patients with tear film instability. In contrast, HA-based formulations primarily improve hydration with limited impact on optical performance. Artificial tear selection should consider both symptomatic relief and refractive stability, especially for individuals with high visual demands.</p> Clinical Trial Registration <p>This study was registered as a randomized clinical trial on ClinicalTrials.gov under the identifier NCT06784661, titled the ILEACT study.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Immediate Impact of Artificial Tear Composition on Optical Aberrations: A Comparative Study of Lipid and Non-Lipid Hydroxypropyl Guar Formulations

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月17日

查看全文
  • José-María Sánchez-González,
  • María Carmen Sánchez-González,
  • Concepción De-Hita-Cantalejo,
  • Henrique Nascimento,
  • Clara Martinez-Perez

摘要

Introduction

To evaluate the immediate effects of two artificial tear formulations—mineral oil + hydroxypropyl guar (HP-Guar) and hyaluronic acid (HA) + HP-Guar—on ocular aberrations in healthy participants.

Methods

A randomized, participant-masked clinical trial was conducted on 98 right eyes of 98 participants (mean age: 27.96 ± 10.00 years). Participants received a single instillation of either a lipid-based (mineral oil + HP-Guar) or non-lipid (HA + HP-Guar) artificial tear solution. Ocular aberrations were measured before and 10 min post-instillation using a wavefront aberrometer (i.Profilerplus®, Carl Zeiss Meditec, Jena, Germany) at pupil diameters of 3 mm and 5 mm. Root mean square (RMS) values for total, low-order, and high-order aberrations were analyzed.

Results

The mineral oil + HP-Guar formulation significantly reduced total RMS (p < 0.05) and low-order RMS (p < 0.05) at both 3-mm and 5-mm pupil diameters. Notable reductions were observed in defocus (Z20), vertical astigmatism (Z22), and trefoil (Z3−3). Both formulations significantly increased high-order RMS (p < 0.05).

Conclusions

Lipid-based artificial tears provide superior optical quality by reducing total and low-order ocular aberrations, making them preferable for patients with tear film instability. In contrast, HA-based formulations primarily improve hydration with limited impact on optical performance. Artificial tear selection should consider both symptomatic relief and refractive stability, especially for individuals with high visual demands.

Clinical Trial Registration

This study was registered as a randomized clinical trial on ClinicalTrials.gov under the identifier NCT06784661, titled the ILEACT study.